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Abstract
Parkinson’s disease (PD) is associated with various cognitive impairments. However, the
nature of cognitive modification in patients with PD remains to be elucidated. In the present
study, we examined whether patients with PD could correct and maintain subjective time
duration and line length estimation. After training sessions, in which participants repeatedly
memorized either a duration or a length, we compared a learning performance in 20 PD
patients with 20 healthy controls. In the case of duration in the PD patients, the learned dura-
tions immediately returned to baseline of pre-training within a few minutes. However, the
patients’ ability to learn length estimation remained unimpaired. In contrast, healthy controls
were able to retain the learned duration and length estimations. Time compression in PD’s
internal clock may become entrained to their altered duration estimation even after learning
of accurate time duration. These deficits may be associated with disrupting cognitive modifi-
cation in PD.
Introduction
The ability to accurately recognize time duration is fundamental to everyday life, and self-set-
ting of time duration without cues is affected by various factors [1, 2]. Some neurological dis-
eases, particularly Parkinson’s disease (PD), involve disordered temporal processing [3, 4].
Patients with PD have decreased levels of dopamine (DA), as well as various impairments to
cognitive function [5–7]. In particular, they tend to underestimate time duration [8]. Adminis-
tration of DA agonists causes a shift toward normal perception of time duration [9], indicating
that DA levels are associated with time estimation, and therefore that the basal ganglia are
involved in temporal processing [10, 11]. Moreover, striatal activity plays a major role in the
acquisition and early maintenance stages of instrumental learning [12]. Patients with PD
develop cognitive learning disabilities, including difficulties with decision-making, attention,
and visual discrimination [13–16]. DA is a substrate for synaptic plasticity and memory
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formation [17], and it may be that patients with basal ganglia disorders cannot adjust their
behavior to situational demands.
The learning mechanisms underlying estimation of time duration and length have not yet
been examined, even in healthy individuals. Nonetheless, it follows that, if striatum deficits
affected learning across cognitive tasks, patients with PD would experience dysfunctional esti-
mation of both time duration and length. In contrast, if learning was only dysfunctional in one
dimension, cognitive modification would specifically be lost in that dimension, rather than
more generally. Because time duration estimation shows severe disruption [9, 18] while length
estimation is normal in patients with PD [19], it may be that cognitive function is lost within
that specific dimension. Therefore, the time durations produced by patients would immedi-
ately return to their baseline values, even after the patients had learned the correct time dura-
tion, while lengths produced by patients would remain accurate.
In the present study, we conducted behavioral experiments to test a learning ability in both
time duration and line length estimations (“Estimation training task”) by comparison of PD
patients with healthy controls (HCs). To examine memory ability, we confirmed that all partic-
ipants could reproduce the line length and time duration after 5 minutes (“Delayed reproduc-
tion task”).
Methods
Standard protocol approvals, registration, and patient consents
This study was approved by the Ethics Committees of Showa University Hospital (clinical trial
identifier number: 4192) and was conducted according to the Principles of the Declaration of
Helsinki. All participants provided written informed consent.
Participants
Sample size was determined by effect size in previous studies related to cognition and leaning
[8–10,18,19]. In case-controlled study design, Clinical neurologists recruited 43 patients with
PD who met the diagnostic criteria of the Parkinson’s Disease Society Brain Bank [20]. Among
them, 20 were selected to participate in this study. Participants were included if they had no
signs of dementia, as determined by two cognitive assessment batteries: the Mini-Mental Sta-
tus Examination (MMSE; score> 25), which tests memory, attention, and language abilities
[21]; and the Montreal Cognitive Assessment (MoCA; score> 25), which tests memory, visuo-
spatial, executive, attention, concentration, and language abilities [22]. For both the MMSSE
and MoCA, we used a cut-off score of “> 25”. We excluded any patients at the lower limit of
either the MMSE or MoCA. We also recruited 26 elderly HCs with no history of neurological
disease and no signs of dementia. Among them, we excluded six who overestimated time dura-
tion (by judging objective 22 s duration as more than 23 s subjectively). The learning effect
may take different meanings, in that an overproduced person learned a standard duration of
22 s (toward short duration) from in that an underproduced person learned the duration
(toward long duration). Along with the reason that overproduced persons were a small group,
we excluded 6 HCs from the current analysis, to clear the effect.
There was no significant difference in age between the HC and PD groups, and all partici-
pants were right-handed (Table 1). Patients with PD and HCs showed no brain abnormalities
on magnetic resonance imaging (MRI) with fluid-attenuated inversion recovery and diffu-
sion-weighted imaging. PD severity was measured with the Unified Parkinson’s Disease Rating
Scale [23], the Hoehn–Yahr scale, and disease duration. All patients were taking L-dopa or a
DA agonist (carbidopa/levodopa equivalent daily dose). Patients with PD participated in
behavioral experiments in the On condition, under which medicine was being administered.
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Behavioral measurements
We conducted a delayed reproduction task and estimation training task for time duration and
line length. We used time durations of 11 s and 22 s, because these allowed us to investigate
conscious behavior, unlike millisecond or circadian scales. Furthermore, previous researches
clearly reported differences between healthy controls and PD patients using this time scale [18,
19]. The delayed reproduction task was conducted at the start. Three to four weeks later, we
conducted an estimation training task. In both tasks, the participants were asked to estimate a
specified time duration or line length with their right hand by holding a stylus pen above an
electronic tablet (Intuos4 Extra Large, WACOM Corporation, Saitama, Japan; spatial preci-
sion, ±0.25 mm; sampling rate, 200 points/s, screen size, 488 mm × 305 mm; frame size, 623
mm × 462 mm). At the beginning of each trial, the duration or length to be estimated was ver-
bally mentioned by the experimenter (S1 Video).
Delayed reproduction. In the delayed reproduction task of length, the participants were
asked to memorize and, after 5 minutes, to reproduce the length of a line on a computer screen
(Fig 1A). The line was either 11 or 22 cm and was presented for 11 s. In the delayed reproduction
task of duration, the participants were asked to memorize and, after 5 minutes, to reproduce the
duration of presentation of a circle (Fig 1B). The circle was presented for either 11 or 22 s. The par-
ticipants started each trial when they were ready and tapped the tablet with the pen at the begin-
ning and end of the pen’s trajectory. Each task consisted of two trials, and intervals of minute-long
were interposed between trials. The order was randomized between duration and length tasks.
Estimation training. In the length production task, the participants were asked to move
the pen to the right for a length of 22 cm (Fig 2A). In the duration production task, the partici-
pants were asked to tap the tablet with a pen to start, wait for 22 s, and to tap the tablet again
for the end of measurement (Fig 2B). The experiment consisted of four consecutive sessions:
(1) test (two trials), (2) training (five trials), (3) retest (five trials), and (4) added retest (two tri-
als). Intervals of minute-long were interposed between trials.
During the test, retest, and added-retest sessions, the participants completed the task with-
out any cue. In the training session, a ruler cue for the length task and a clock cue for the dura-
tion task were provided in each trial. The ruler cue was a drawing of a ruler with its scale in
Table 1. Participant details.
HC PD t p







MMSE 27.35 (1.09) 27.00 (1.34) 0.101 0.920
MoCA 27.35 (1.23) 26.99 (1.08) 0.321 0.750
UPDRS - 39.74 (27.65)
LEDD 337.50 (167.71)
Hoehn-Yahr stage - 2.70 (0.86)
PD duration (years) - 7.25 (4.61)
HC: elderly Healthy Control. PD: patient with Parkinson’s Disease. MMSE: Mini-Mental State Examination (max: 30). MoCA: Montreal Cognitive Assessment (max:
30). UPDRS: Unified Parkinson’s Disease Rating Scale. LEDD: Levodopa Equivalent Daily Dose. The standard deviations are shown in parentheses.
https://doi.org/10.1371/journal.pone.0208956.t001
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millimeters and a maximum value of 30 cm. Where movement of the pen was required, the
participants were asked to move it as constantly as possible and to keep it 5–10 mm above the
surface of the tablet to avoid undesirable occasional contact to the surface because of tremor
symptoms that must be considered in patients with PD. The clock cue was a drawing of an
analog clock with its dial scaled in seconds, and a maximum value of 60 s. The second hand
moved in smooth rotation as with a real clock. Finally, we repeated the duration/length estima-
tion tasks for 11 cm and 11 s, respectively. This confirmed any generalization effect of estima-
tion. The order was randomized between the length and duration tasks.
Statistical analysis
Repeated measures analysis of variance (ANOVA) and t tests were conducted for behavioral per-
formance and screening scores. Duration and length data were analyzed separately in both delayed
reproduction and estimation training tasks. In addition, the 11/22 cm and 11/22 s conditions were
analyzed independently. All tests were two-tailed. The results are shown as the mean ± standard
error of mean and effect size (eta squared, η2). Statistical significance was defined as p< 0.05.
Results
Delayed reproduction
No significant differences were observed in the reproduced time durations and line lengths
between the PD and HC groups (Fig 1C and 1D). Comparison between groups confirmed the
Fig 1. Delayed reproduction task. (A) Line length was estimated by drawing a line with a pen to reproduce line length
(11 or 22 cm) after 5 minutes. The sample line was presented for 11 s. (B) Time duration was estimated by tapping a
tablet with a pen to reproduce a sample presentation (11 or 22 s) after 5 minutes. (C) The estimated lengths did not
differ between healthy controls (HC) and patients with Parkinson’s disease (PD) in the tasks involving both the 11 cm
and 22 cm lines. (D) The estimated durations did not differ between the HC and PD groups in the tasks involving both
11 s and 22 s durations.
https://doi.org/10.1371/journal.pone.0208956.g001
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absence of significant differences in reproduced duration/length across all conditions (S1
Table). Thus, all participants could reproduce both durations and lengths with a 5-minute
delay.
Estimation training
Length estimation. In the test session, the estimated length did not differ between the
groups (t38 = 0.133, p = 0.895). Furthermore, the average length in test sessions was shorter
than that in the first trial of the training session in both PD (t19 = 14.554, p< 0.0001) and HC
(t19 = 12.349, p< 0.0001) groups (Fig 2C). Thus, PD did not appear to affect estimated lengths,
although the lengths estimated by both PD and HC groups were shorter than the accurate
length.
Repeated measures ANOVA showed no main effects of group (F1, 38 = 0.133, p = 0.718, η2 =
0.003), retest session (F4, 152 = 1.427, p = 0.228, η2 = 0.036), or the interaction (F4, 152 = 0.486,
p = 0.746, η2 = 0.013). In addition, the length estimated in the last trial of the training session
did not differ from that in all trials of the retest session in either PD or HC group (S2 Table). In
contrast, the estimated lengths in all trials of the retest session were longer than those in the test
session in both the PD (trial 1: t19 = 10.266 p< 0.0001; trial 2: t19 = 12.340, p< 0.0001; trial 3:
t19 = 13.223, p< 0.0001; trial 4: t19 = 12.134, p< 0.0001; and trial 5: t19 = 12.168, p< 0.0001)
and HC groups (trial 1: t19 = 9.437, p< 0.0001; trial 2: t19 = 10.987, p< 0.0001; trial 3: t19 =
11.934, p< 0.0001; trial 4: t19 = 13.139, p< 0.0001; and trial 5: t19 = 13.034, p< 0.0001). This
suggests a training effect in both groups, and the effect was retained during the retest session.
In the added-retest session with estimation of an 11 cm line, the average estimated length in
the PD group did not differ from that in the HC group (t38 = 1.678, p = 0.112). Data from
Fig 2. Estimation training task. (A) Line length was estimated by drawing a line with a pen without a cue in the test, retest, and added-retest sessions
(left), and with a ruler cue in the training session (right). (B) Time duration was estimated by tapping the tablet with a pen without a cue in the test, retest,
and added-retest sessions (left), and with a clock cue in the training session (right). (C) The estimated lengths did not differ between healthy controls (HC)
and patients with Parkinson’s disease (PD) in any session. However, there were differences in performance between the second test and first training
session in both HCs and patients with PD. (D) Estimated durations differed between the HC and PD groups in the test, retest, and added-retest sessions.
Performance differed between the average of the test session and the first trial of the training session in both the HC and PD groups. Furthermore, the last
trial of the training session differed from all trials in the retest session in the PD group.
https://doi.org/10.1371/journal.pone.0208956.g002
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twice in the added-retest session did not differ from the last trial of the retest session in either
PD (t19 = 1.978, p = 0.089) or HC (t19 = 1.929, p = 0.081) group. This suggests that the estimated
length was generalized, and the generalization effect was retained in the added-retest session.
Duration estimation. During time duration estimation, in the test session, patients with
PD estimated a shorter duration than did HC (Fig 2D). Comparison between groups showed
that the duration was significantly shorter in the PD group than in the HC group (t38 = 5.567,
p< 0.0001). Furthermore, the comparison revealed that the average duration of the test ses-
sion was shorter than that of the first trial in the training session in both PD (t18 = 11.006,
p< 0.0001) and HC (t19 = 5.789, p< 0.001) groups. Thus, the estimated-duration in the HC
group was shorter than the accurate duration estimated with the clock cue, while the estimated
duration in the PD group was much shorter than the duration estimated with the clock cue.
In the PD group, the durations estimated in the five trials of the retest session were shorter
than those in the last trial of the training session (trial 1: t19 = 2.965, p = 0.009; trial 2: t19 =
6.780, p< 0.0001; trial 3: t19 = 8.978, p< 0.0001; trial 4: t19 = 10.897, p< 0.0001; and trial 5: t19
= 14.56, p< 0.0001). In contrast, there was no difference in the HC group (all p> 0.05). In the
retest session, the PD group estimated shorter durations than did the HC group.
Repeated measures ANOVA revealed main effects of group (F1, 38 = 86.522, p< 0.0001,
η2 = 0.695), training effect on retest session (F4, 152 = 10.143, p< 0.0001, η2 = 0.221), and the
interaction (F4, 152 = 7.913, p< 0.0001, η2 = 0.172). Post hoc tests showed that durations were
shorter in the PD group than in the HC group for all trials in the retest session (trial 1, adjusted
p< 0.001; trial 2, p< 0.0001; trial 3, p< 0.0001; trial 4, p< 0.0001; and trial 5, p< 0.0001).
Furthermore, the durations in the retest session of the PD group were negatively correlated
with the trial numbers (r = −0.991, p< 0.0001), whereas those in the HC group were not corre-
lated with the trial number (r = −0.290, p = 0.635). In brief, the modified duration estimated
by patients with PD returned gradually to the pre-training duration within a few minutes,
while the HCs retained the duration during the retest session.
In the added-retest session of 11 s duration estimation, comparison between groups
revealed that the average estimated duration was shorter in the PD group than in the HC
group (t38 = 8.136, p< 0.0001). Data from twice in the added-retest session did not differ from
the last trial of the retest session of patients with the PD (t19 = 1.778, p = 0.157) or HC group
(t19 = 1.989, p = 0.068). This suggests that the estimated duration was generalized, and the gen-
eralization effect was retained in the added-retest session.
Discussion
In the present study, both HCs and patients with PD had normal memory ability for both time
duration and line length in the delayed reproduction task. Furthermore, HCs could modify
their estimated duration/length during estimation training and retain these modifications for
5 minutes after training. However, patients with PD failed to learn the modified durations, but
could retain the modified length estimation. Our findings suggest that PD impairs learning of
duration specifically, rather than learning function more generally.
The lengths estimated by the patients with PD did not differ significantly from those esti-
mated by HCs in the test and retest sessions. However, the patients with PD underestimated
the durations in their sessions. Previous study has shown that reduced DA levels lead to hyper-
activity or rapid signal cycling in the globus pallidus and subthalamic nuclei [24, 25]. Relatedly,
fast mental counting of time (time compression) may be associated with hyper-activity or fast
signal cycles in a loop system, such as the striatum–pallidus–thalamus–cortex loop [26], and
extreme time compression can be consolidated due to prolonged symptoms in patients with
PD, making it difficult to modify duration estimation.
Impaired modification for duration production in PD
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Performance on the delayed reproduction task was normal in patients with PD. This task is
thought to depend on memory ability. For example, when a patient estimated a duration of objec-
tive 22 s as being subjective 16 s, we rated the answer as accurate if the patient retained and repro-
duced the subjective 16 s duration. The underestimated durations in the test session may reflect
truly dysfunctional time processing that is independent of memory ability in the delayed repro-
duction task [18]. Although patients with PD may be able to maintain their own duration easily,
they may find it difficult to modify their duration. Thus, PD may not affect memory function for
durations, but it may strongly affect the estimation and learning of durations.
Notably, durations estimated by patients with PD shortened gradually over several few min-
utes, indicating that the training effects were retained for a short time. This suggests that there
is a time window during which the process of duration training is lost, and therefore that an
effect of duration training may be supported by working memory [27, 28]. Previous studies
have reported that working memory in patients with PD is dysfunctional [29]. However,
patients in the present study accurately estimated durations during the delayed reproduction
task. Thus, patients with PD underestimated duration but had normal memory for duration. It
follows that, particularly in the first trial, the estimated duration in the retest session may indi-
cate that the tendency of the “clock system to return to its original state” and the property of
the “memory system to retain information” act antagonistically.
The present study had several limitations. Firstly, the dimensions of time duration and line
length are not directly comparable, and the difficulty of the task also differed between the two.
That is, the comparison between duration and length estimations may depend on the difficulty
of task. To ascertain whether the deficits observed are a property of duration estimation specif-
ically, experiments involving a variety of tasks will be necessary. Secondly, we used two screen-
ings for mild cognitive impairment and suspicion of dementia, and the cutoff values were 26
points in both cases. The MoCA is much more sensitive than the MMSE in the classification of
cognitive impairment in PD [30], so we might have adopted standards for respective cutoff val-
ues [31]. However, because a few patients had a lower score in the MMSE than in the MoCA
in our past study, we excluded all patients at the lower limit of either test. This increased the
probability that all participants with mild cognitive impairment or dementia were excluded.
Finally, we did not assess the severity of depression in the present study. It has been reported
that depression affects time estimation [32], and that patients with PD have a high incidence of
depression [33]. Therefore, the influence of depression remains a potential confounder for the
effect of PD on the learning of duration estimation.
The current study showed cognitive modification after training in duration estimation in
HCs, suggesting that healthy people have the flexibility to alter awareness of duration. Future
research should investigate how long these training effects can be maintained and whether
these people can consolidate modified duration estimation in daily life. In contrast, the flexi-
bility of duration estimation was lost in patients with PD, perhaps because of extreme time
compression. Previous studies in patients with PD have reported that DA agonists lead to
a shift in duration estimation towards normal [9], indicating that duration estimation is
related to dopaminergic neurons. The current study suggested that PD impairs modification
of duration estimation, while modification of length estimation remained possible. When
impaired dopaminergic neurons affect cognitive function, learning disability may occur in the
corresponding function. In this regard, it is known that PD impairs a recognition of facial
expression [34]. Future research should address whether patients with PD show a learning
impairment for recognition of facial expression. Finally, distorted duration estimation is
reported in a wide variety of conditions, such as depression [32], epilepsy [35], schizophrenia
[36], and attention-deficit hyperactivity disorder [37]. These conditions involve dopaminergic
neurons, and the extension and reduction of duration estimation correspond to deficiency and
Impaired modification for duration production in PD
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excess of DA, respectively. Further investigation is required to elucidate the effect of these dis-
eases on learning of duration estimation.
Supporting information
S1 Video. A representative trial of length estimation training without cues in a patient
with Parkinson’s disease.
(MP4)
S1 Table. Group comparisons in the delayed reproduction task.
(PDF)
S2 Table. Differences in the length estimation training task between the last trial in the
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